These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15542718)

  • 21. Neural plasticity and addiction: integrin-linked kinase and cocaine behavioral sensitization.
    Chen Q; Xiong X; Lee TH; Liu Y; Wetsel WC; Zhang X
    J Neurochem; 2008 Nov; 107(3):679-89. PubMed ID: 18702665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects.
    Dafny N; Yang PB
    Brain Res Bull; 2006 Feb; 68(6):393-405. PubMed ID: 16459193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission.
    Kalivas PW; Volkow N; Seamans J
    Neuron; 2005 Mar; 45(5):647-50. PubMed ID: 15748840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment.
    Lile JA
    Exp Clin Psychopharmacol; 2006 Feb; 14(1):20-33. PubMed ID: 16503702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The dopaminergic system and addictions].
    Corominas-Roso M; Roncero C; Bruguera E; Casas M
    Rev Neurol; 2007 Jan 1-15; 44(1):23-31. PubMed ID: 17199226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration.
    Zhang GC; Mao LM; Liu XY; Wang JQ
    J Neurochem; 2007 Oct; 103(1):400-7. PubMed ID: 17623047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosing time-dependent actions of psychostimulants.
    Manev H; Uz T
    Int Rev Neurobiol; 2009; 88():25-41. PubMed ID: 19897073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural plasticity of the brain to psychostimulant use.
    Nyberg F
    Neuropharmacology; 2014 Dec; 87():115-24. PubMed ID: 25018041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAAR1 and Psychostimulant Addiction.
    Liu J; Wu R; Li JX
    Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of intake and drug craving predict the development of cocaine addiction-like behavior in rats.
    Belin D; Balado E; Piazza PV; Deroche-Gamonet V
    Biol Psychiatry; 2009 May; 65(10):863-8. PubMed ID: 18639867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prenatal and postnatal maternal ethanol on offspring response to alcohol and psychostimulants in long evans rats.
    Barbier E; Houchi H; Warnault V; Pierrefiche O; Daoust M; Naassila M
    Neuroscience; 2009 Jun; 161(2):427-40. PubMed ID: 19348874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray studies of psychostimulant-induced changes in gene expression.
    Yuferov V; Nielsen D; Butelman E; Kreek MJ
    Addict Biol; 2005 Mar; 10(1):101-18. PubMed ID: 15849024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro assessment of neuropsychotoxicity of abused drugs using organotypic slice cultures].
    Nakagawa T; Kaneko S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):166-71. PubMed ID: 18646642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of serotonin 5-HT1B receptors in psychostimulant addiction.
    Miszkiel J; Filip M; Przegaliński E
    Pharmacol Rep; 2011; 63(6):1310-5. PubMed ID: 22358079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.
    Anderson SM; Pierce RC
    Pharmacol Ther; 2005 Jun; 106(3):389-403. PubMed ID: 15922019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased central brain-derived neurotrophic factor activity could be a risk factor for substance abuse: Implications for treatment.
    Tsai SJ
    Med Hypotheses; 2007; 68(2):410-4. PubMed ID: 16824691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic responses to self-administered cocaine in Rhesus monkeys do not sensitize following high cumulative intake.
    Bradberry CW; Rubino SR
    Eur J Neurosci; 2006 May; 23(10):2773-8. PubMed ID: 16817880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of dopamine receptors and drug addiction: a comprehensive review.
    Le Foll B; Gallo A; Le Strat Y; Lu L; Gorwood P
    Behav Pharmacol; 2009 Feb; 20(1):1-17. PubMed ID: 19179847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the endogenous cannabinoid system in drug addiction.
    Parolaro D; Rubino T
    Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.